Navigation Links
AMERIGROUP Updates 2008 Guidance to Reflect Yesterday's Federal Reserve Action
Date:3/19/2008

First Quarter Seasonality Consistent with Expectations

VIRGINIA BEACH, Va., March 19 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP) announced today that it has updated its guidance for the full year 2008 to $2.46 to $2.61 per diluted share from the previously announced range of $2.58 to $2.73 to reflect yesterday's Federal Reserve action reducing the Federal Funds Rate by 75 basis points, which will have a corresponding impact on market interest rates.

"Since we announced our initial 2008 guidance last October, the Federal Reserve has lowered the Federal Funds Rate substantially," said James W. Truess, AMERIGROUP's Executive Vice President and Chief Financial Officer. "We have been able to absorb previous rate cuts by the Federal Reserve in our guidance, we believe yesterday's action will further impact us during the remainder of 2008."

The Company also announced that, while the winter season is not yet complete, medical costs in the first quarter of 2008 have thus far been within the range of historical seasonal patterns. Based on paid claims data for the first two months of 2008, the Company's December 2007 reserves appear to be adequate.

2008 Outlook

AMERIGROUP's updated 2008 annual earnings estimates of $2.46 to $2.61 per diluted share are predicated on the following assumptions, among others:
-- Organic premium revenue growth is expected to be above 15%;

-- Investment income and other revenue growth is expected to be flat to

slightly above the prior year;

-- Health benefits ratio in the mid 83% range of premium revenues for the

full year;

-- Selling, general and administrative expenses below 12% of total

revenue; and

-
'/>"/>

SOURCE AMERIGROUP Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. AMERIGROUP Corporation to Present at the Lehman Brothers Global Healthcare Conference on March 20
2. Texas Senator Robert Duncan Honored as Champion for Children by The AMERIGROUP Foundation
3. AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share
4. Texas Senator Tommy Williams Honored as Champion for Children by the AMERIGROUP Foundation
5. AMERIGROUP Foundation Announces Winners of Word About Health Contest
6. AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services
7. AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA
8. AMERIGROUP Foundation Awards $100,000 to Grady Health System Foundation in Atlanta
9. AMERIGROUP Community Care Provides Doctors Office Makeover in Houston
10. AMERIGROUP Corporation to Present at the Merrill Lynch Health Services Investor Conference on November 27
11. AMERIGROUP Corporation to Present at the 2007 Credit Suisse Healthcare Conference on November 13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... EcoHealth Alliance, a nonprofit organization that focuses on conservation ... today examining the current state of knowledge of the ... improved global surveillance strategies to combat the emergence of ... in West Africa that has claimed the lives of ... According to the World Health Organization (WHO), the ...
(Date:4/17/2014)... Spending time online has the potential to ward off ... according to research published online in The ... Sciences . In the article " Internet Use ... States: A Longitudinal Analysis ," the authors report that ... by 33 percent among their study sample. , ...
(Date:4/17/2014)... Council scientists and their partners have found that their ... the transmission of multiple sexually transmitted infections (STIs) in ... simplex virus 2 (HSV-2), and human papillomavirus (HPV). The ... gel is effective against multiple strains of HIV, and ... all three viruses of at least eight hours prior ...
(Date:4/17/2014)... WINSTON-SALEM, N.C. April 17, 2014 Meaningful ... from advanced cancer of the abdomen when treated ... HIPEC, according to a first-of-its-size analysis by physicians ... Forest Baptist has the largest reported, single-center experience ... Edward A. Levine, M.D., and analysis of 20 ...
(Date:4/17/2014)... D.C. -- The world is less than 40 years ... implications for people and governments, according to a top ... the first time in human history, food production will ... of land, water and energy," said Dr. Fred Davies, ... security. "Food issues could become as politically destabilizing by ...
Breaking Medicine News(10 mins):Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:Food shortages could be most critical world issue by mid-century 2
... by the Dana-Farber Cancer Institute shows more than half ... developing treatment-related infertility problems.// ,Nearly 700 members ... were 40 years old or younger were surveyed. More ... they were concerned about being infertile as a result ...
... by nurses and dieticians have been found effective in ... shown they work only when these health professionals are ... at a program in which patients received their medications ... and dieticians on factors aimed at improving their cardiovascular ...
... therapeutic option for patients with complicated type 1 diabetes, ... // Now, a new study finds ... worse survival than patients on the transplant waiting list ... Association supports a pancreatic transplant for patients who have ...
... have identified a molecule that may help older people ... cells, called satellite cells, that line the outside of ... to form new muscle tissue. They also generate new ... cells respond when a certain protein called Notch is ...
... reports, patients who were treated for depression responded better ... in their blood.// ,An increasing amount of research ... depression, but the specifics have not been understood. Researchers ... vitamin B12 and the treatment of depression. ,The ...
... suggests a common antipsychotic drug might have caused a pulmonary ... pulmonary embolism results when a blood clot that developed elsewhere ... be deadly. Antipsychotic drugs have been linked to an increased ... shown an association between blood clots and the drug clozapine. ...
Cached Medicine News:Health News:Pancreas Transplant for Diabetics 2
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
(Date:1/15/2014)... LAVAL, Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... 2 data continue to show encouraging anti-tumor activity in,non- small cell ... ... XL647 administration, SAN FRANCISCO, Oct. 24 Exelixis, Inc.,(Nasdaq: ... study of XL647,an inhibitor of EGFR, HER2 and VEGFR kinases, in ...
... Clinical Studies TAX 323 and TAX 324 Published, ... that results of two clinical studies demonstrating that,Taxotere(R) ... fluorouracil for induction therapy, significantly improved overall,survival (OS) ... of,the head and neck (SCCHN) are published in ...
Cached Medicine Technology:Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 2Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 3Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 4Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7
... Exceptional comfort for those with ... Toric soft contact lenses let you enjoy ... other soft toric lensa difference youll especially ... throughout the day., This exceptional level of ...
Frequency 55 Toric monthly soft toric lenses....
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Medicine Products: